HomeAI · summaries
Storia in 6 fonti
Trump may be mystery patient in odd case of 79yo getting experimental obesity drug
Public notice of a single "compassionate use" case is odd in every way.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
newrepublic.com
Remember That Time Trump Said He “Probably Should” Take Ozempic?
A bombshell report about how a 79-year-old man got early access to a weight loss drug has all eyes on the president.
- ·
Eli Lilly Approved Obesity Drug for Mystery 79-Year-Old Patient
Questions are swirling over Donald Trump’s health after a bombshell report revealed a mystery man was getting unprecedented access to a weight-loss drug.
- ·
statnews.com
Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?
Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental obesity drug through the agency’s “compassionate use”…
- ·
arstechnica.com
Trump may be mystery patient in odd case of 79yo getting experimental obesity drug
Public notice of a single "compassionate use" case is odd in every way.
- ·
huffpost.com
It Kinda Looks Like Trump Might Be Taking An Experimental Obesity Drug?
Retatrutide has not been approved by the FDA, but precisely one 79-year-old man was granted access via "compassionate use."
- ·
gizmodo.com
Just Who Is the Mystery 79-Year-Old Patient Who Got Special Access to an Experimental Weight Loss Drug?
The White House has denied that the application was filed on behalf of President Donald Trump.
- ·
independent.co.uk
White House denies Trump is the mystery patient who got early access to obesity drug
A White House spokesman said theories that President Trump sought the drug were ‘baseless speculation’
- ·
White House denies Trump was mystery patient given early access to weight-loss drug
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleWhite House officials are denying that…